Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis

Sparber-Sauer, Monika; Orbach, Daniel; Navid, Fariba; Hettmer, Simone; Skapek, Stephen; Corradini, Nadege; Casanova, Michela; Weiss, Aaron; Schwab, Matthias; Ferrari, Andrea

dc.contributor.author	Schwab, Matthias
dc.date.accessioned	2022-08-22T06:47:25Z
dc.date.available	2022-08-22T06:47:25Z
dc.date.issued	2021
dc.identifier.issn	0007-0920
dc.identifier.uri	http://hdl.handle.net/10900/131093
dc.language.iso	en	de_DE
dc.publisher	London	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41416-021-01320-1	de_DE
dc.subject.ddc	610	de_DE
dc.title	Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_02383
utue.publikation.seiten	1637-1646	de_DE
utue.personen.roh	Sparber-Sauer, Monika
utue.personen.roh	Orbach, Daniel
utue.personen.roh	Navid, Fariba
utue.personen.roh	Hettmer, Simone
utue.personen.roh	Skapek, Stephen
utue.personen.roh	Corradini, Nadege
utue.personen.roh	Casanova, Michela
utue.personen.roh	Weiss, Aaron
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Ferrari, Andrea
dcterms.isPartOf.ZSTitelID	British Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	10	de_DE
dcterms.isPartOf.ZS-Volume	124	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE